High rates of early treatment discontinuation in hepatitis C-infected US veterans

BACKGROUND: Patients with chronic hepatitis C (HCV) frequently discontinued dual therapy with pegylated interferon alfa (Peg-IFN) plus ribavirin (RBV) before reaching the recommended duration of 48 or 24 weeks for genotypes (G) 1/4 or 2/3, respectively. We quantified rates of discontinuation despite...

Descripción completa

Detalles Bibliográficos
Autores principales: LaFleur, Joanne, Hoop, Robert, Morgan, Timothy, DuVall, Scott L, Pandya, Prashant, Korner, Eli, Knippenberg, Kristin, Hayden, Candace, Nelson, Richard E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012175/
https://www.ncbi.nlm.nih.gov/pubmed/24758162
http://dx.doi.org/10.1186/1756-0500-7-266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012175/
https://www.ncbi.nlm.nih.gov/pubmed/24758162
http://dx.doi.org/10.1186/1756-0500-7-266

Ejemplares similares